| Thomas Michael Nicholas, OD | |
|
1204 W Willow Rd, Suite A, Enid, OK 73703-2531 | |
| (580) 234-2333 | |
| (580) 234-0820 |
| Full Name | Thomas Michael Nicholas |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 52 Years |
| Location | 1204 W Willow Rd, Enid, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467540674 | NPI | - | NPPES |
| 848 | Other | OK | STATE LICENSE NUMER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 848 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nicholas Eye Clinic, Pllc | 5092752402 | 2 |
News Archive
The World Health Organization (WHO) violated sound standards of medical care and human rights by nudging poorer countries to follow less expensive, untested and largely ineffective treatment protocols for tuberculosis patients, a new paper by researchers at Duke, Brandeis and Harvard universities argues.
In the management of gliomas-or tumors that originate in the brain-precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival.
SNM will hold its Conjoint Mid-Winter Meetings Jan. 27-Feb. 2, 2010, at the Albuquerque Convention Center in Albuquerque, N.M. This year, SNM joins its annual Mid-Winter Educational Symposium with the 2010 Annual Meeting and Educational Symposium of the American College of Nuclear Medicine (ACNM), the Nanomedicine and Molecular Imaging Summit and the Clinical Trials Network Community Workshop.
Zytoprotec, a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec.
› Verified 5 days ago
| Provider Name | Nicholas Eye Clinic, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487789913 PECOS PAC ID: 5092752402 Enrollment ID: O20050415000699 |
News Archive
The World Health Organization (WHO) violated sound standards of medical care and human rights by nudging poorer countries to follow less expensive, untested and largely ineffective treatment protocols for tuberculosis patients, a new paper by researchers at Duke, Brandeis and Harvard universities argues.
In the management of gliomas-or tumors that originate in the brain-precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival.
SNM will hold its Conjoint Mid-Winter Meetings Jan. 27-Feb. 2, 2010, at the Albuquerque Convention Center in Albuquerque, N.M. This year, SNM joins its annual Mid-Winter Educational Symposium with the 2010 Annual Meeting and Educational Symposium of the American College of Nuclear Medicine (ACNM), the Nanomedicine and Molecular Imaging Summit and the Clinical Trials Network Community Workshop.
Zytoprotec, a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Michael Nicholas, OD 1204 W Willow Rd, Suite A, Enid, OK 73703-2531 Ph: (580) 234-2333 | Thomas Michael Nicholas, OD 1204 W Willow Rd, Suite A, Enid, OK 73703-2531 Ph: (580) 234-2333 |
News Archive
The World Health Organization (WHO) violated sound standards of medical care and human rights by nudging poorer countries to follow less expensive, untested and largely ineffective treatment protocols for tuberculosis patients, a new paper by researchers at Duke, Brandeis and Harvard universities argues.
In the management of gliomas-or tumors that originate in the brain-precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival.
SNM will hold its Conjoint Mid-Winter Meetings Jan. 27-Feb. 2, 2010, at the Albuquerque Convention Center in Albuquerque, N.M. This year, SNM joins its annual Mid-Winter Educational Symposium with the 2010 Annual Meeting and Educational Symposium of the American College of Nuclear Medicine (ACNM), the Nanomedicine and Molecular Imaging Summit and the Clinical Trials Network Community Workshop.
Zytoprotec, a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec.
› Verified 5 days ago
Dr. Michael Lloyd Peck, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 517 W Maine Ave, Enid, OK 73701 Phone: 580-242-2300 Fax: 580-233-7370 | |
Chase Ratzlaff, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1204 W Willow Rd Ste A, Enid, OK 73703 Phone: 580-234-2333 | |
Premier Eyecare Of Enid Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 517 W Maine Ave, Enid, OK 73701 Phone: 580-242-2300 Fax: 580-233-7370 | |
Bethany Hess, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 705 S Oakwood Rd Ste C1, Enid, OK 73703 Phone: 580-237-9379 | |
Dr. Luanne Danes, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 527 Gott Rd, Enid, OK 73705 Phone: 580-213-7418 | |
Dr. Thomas M Nicholas Ii, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1204 W Willow Rd, Suite A, Enid, OK 73703 Phone: 580-234-2333 Fax: 580-234-0820 | |
W D Diehl Od Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 502 W Owen K Garriott Rd, Enid, OK 73701 Phone: 580-233-3599 Fax: 580-237-2570 |